passlisted in Coinbase#9 by calls of 844 on this host
0.005 USDC
per call, as the listing declares it on eip155:
- Validation state
- pass
- Uptime, 7 / 30 / 90 days
- 100% / 100% / 100%
- Calls, trailing 30 days
- 2
- Unique payers, trailing 30 days
- 1
- Last called
- 2026-09-28 14:06 UTC
- First observed by TOLLderived
- 2026-09-28
- Pricederived
- 0.005 USDC
- Networks
- 1
How big is this endpoint among the ones like it?
No trace is drawn of this endpoint’s own volume. Its counters have changed 1 time across 9 observations, and 3 changes are the fewest this site will draw a trace through, because two points and a guess are not a series. Every observation is in the JSON.
TOLL's first observation of calc mrecist was 2026-09-28.
At api.magentlab.com, calc mrecist takes POST requests, is listed in the Coinbase registry, and falls under the "other" category by TOLL's rules.
On Base, calc mrecist asks 0.005 USDC per call.
Callers of calc mrecist supply a JSON body with the field items.
calc mrecist answered the sweep of 2026-09-30 with a valid 402, as at every sweep since 2026-09-28.
A response from calc mrecist, as declared, includes path, count and items.
Of api.magentlab.com's 844 listings, calc mrecist ranks tied 9th by calls with 248 others.
Over 30 days: 2 calls, one payer.
The last call to calc mrecist came 3 days before the snapshot, 2026-09-28.
Closest in price to calc mrecist within the "other" category: enrich profile at win.oneshotagent.com and ping at www.api-xpay.com.
calc mrecist is priced above 46% of comparable listings in the "other" category.
The wallet paid by calc mrecist is the payee of 844 endpoints on one host.
The seller's tags on calc mrecist are mrecist, hcc, liver and response.
739 other listings in the "other" category declare exactly the same price.
the payment options, as of 2026-10-01 05:50 UTC · method · pinnable
| registry | network | asset | amount | scheme | pay to |
|---|---|---|---|---|---|
| Coinbase | eip155: | USDC | 0.005 USDC | exact | 0x836Be2…c19Ee2 |
the checks, as of 2026-09-30 08:12 UTC · method · pinnableendpoint answered HTTP 402
No named check failed.
Every sweep that observed this endpoint, newest first.
| observed, UTC | state | failed checks | sweep |
|---|---|---|---|
| 2026-09-30 08:12 UTC | pass | 0 | daily-2026-09-30 |
| 2026-09-29 20:22 UTC | pass | 0 | daily-2026-09-29 |
| 2026-09-28 17:30 UTC | pass | 0 | daily-2026-09-28 |
| 2026-09-28 16:46 UTC | pass | 0 | new-after-daily-2026-09-28 |
Presence in a registry, not liveness of the service (method). Newest first.
- listed in Coinbase
From the registry record, not validated by TOLL.the declared schema, as of 2026-09-28 14:06 UTC · method · live
The input and output block
{
"input": {
"body": {
"items": [
{
"new_lesion": false,
"enhancement_disappeared": true,
"viable_sum_increase_ge_20": false,
"viable_sum_reduction_ge_30": false
},
{
"new_lesion": false,
"enhancement_disappeared": true,
"viable_sum_increase_ge_20": false,
"viable_sum_reduction_ge_30": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/mrecist",
"count": 2,
"items": [
{
"formula": "mrecist",
"mrecist": "CR",
"citation": {
"id": "lencioni-2010",
"doi": "10.1055/s-0030-1247132",
"pmid": "20175033",
"title": "Modified RECIST (mRECIST) assessment for hepatocellular carcinoma",
"source": "Semin Liver Dis. 2010;30(1):52-60",
"authors": "Lencioni R, Llovet JM"
},
"criteria": [
{
"met": false,
"factor": "new_lesion"
},
{
"met": false,
"factor": "viable_sum_increase_ge_20"
},
{
"met": true,
"factor": "enhancement_disappeared"
},
{
"met": false,
"factor": "viable_sum_reduction_ge_30"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula_expression": "mrecist first-match: PD if new_lesion or viable_sum_increase_ge_20; else CR if enhancement_disappeared; else PR if viable_sum_reduction_ge_30; else SD (Lencioni 2010 typical intrahepatic target lesions). Not RECIST 1.1. Not EASL necrosis-only. Not the 2019 Llovet +5 mm PD refinement. magent does not read imaging. Not a diagnosis"
},
{
"formula": "mrecist",
"mrecist": "CR",
"citation": {
"id": "lencioni-2010",
"doi": "10.1055/s-0030-1247132",
"pmid": "20175033",
"title": "Modified RECIST (mRECIST) assessment for hepatocellular carcinoma",
"source": "Semin Liver Dis. 2010;30(1):52-60",
"authors": "Lencioni R, Llovet JM"
},
"criteria": [
{
"met": false,
"factor": "new_lesion"
},
{
"met": false,
"factor": "viable_sum_increase_ge_20"
},
{
"met": true,
"factor": "enhancement_disappeared"
},
{
"met": false,
"factor": "viable_sum_reduction_ge_30"
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula_expression": "mrecist first-match: PD if new_lesion or viable_sum_increase_ge_20; else CR if enhancement_disappeared; else PR if viable_sum_reduction_ge_30; else SD (Lencioni 2010 typical intrahepatic target lesions). Not RECIST 1.1. Not EASL necrosis-only. Not the 2019 Llovet +5 mm PD refinement. magent does not read imaging. Not a diagnosis"
}
]
}
}
}Cite this page
The pinned URL below renders this page from the snapshot of 2026-10-01 05:50 UTC and does not change; the live page does, every six hours. Data reuse is under CC BY 4.0 (terms).
Plain text
TOLL, "calc mrecist on api.magentlab.com", snapshot of 2026-10-01 05:50 UTC. https://tollindex.com/e/api-magentlab-com-api-calc-mrecist-a480f6/at/2026-10-01T05-50Z. Accessed [access date].
BibTeX
@misc{toll-e-api-magentlab-com-api-calc-mrecist-a480f6-2026-10-01T05-50Z,
author = {TOLL},
title = {calc mrecist on api.magentlab.com},
howpublished = {\url{https://tollindex.com/e/api-magentlab-com-api-calc-mrecist-a480f6/at/2026-10-01T05-50Z}},
year = {2026},
month = {10},
note = {Pinned view of the snapshot of 2026-10-01 05:50 UTC. Accessed [access date].}
}None yet. Anything submitted through the form below is published here with its outcome.